aTyr Pharma
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $235 | $0 |
Gross Profit | -383 | -535 | -407 |
EBITDA | -16,932 | -15,866 | -15,552 |
EBIT | -17,315 | -16,636 | -15,959 |
Net Income | -16,306 | -15,491 | -14,760 |
Net Change In Cash | 0 | 235 | 0 |
Free Cash Flow | -20,457 | -22,397 | -11,079 |
Cash | 6,805 | 6,808 | 22,544 |
Basic Shares | 72,284 | 66,080 | 59,261 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $353 | $10,386 | $0 | $10,455 |
Gross Profit | -2,388 | 8,691 | -1,304 | -6,836 |
EBITDA | -52,178 | -44,709 | -32,473 | -14,645 |
EBIT | -54,919 | -46,404 | -33,777 | -15,911 |
Net Income | -50,389 | -45,338 | -33,768 | -16,224 |
Net Change In Cash | 353 | 10,386 | 0 | 10,455 |
Free Cash Flow | -37,435 | -43,527 | -33,267 | -15,503 |
Cash | 22,544 | 9,981 | 2,336 | 16,952 |
Basic Shares | 53,606 | 28,419 | 19,080 | 9,160 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.22 |
2024-06-30 | -$0.22 |
2024-03-31 | -$0.23 |
2023-12-31 | -$0.25 |
